RR trades 263.6% below Wall Street's consensus target of $6.00.
Last 12 months price action with 12-month analyst target path
The base valuation assumes RR achieves its forward estimates and maintains a stable P/E multiple of historical averagesx. This scenario reflects the blended consensus of 2 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of September 24, 2026, Richtech Robotics Inc. Class B Common Stock (RR) has a Wall Street consensus price target of $6.00, based on estimates from 2 covering analysts. With the stock currently trading at $1.65, this represents a potential upside of +263.6%. The company has a market capitalization of $303M.
Analyst price targets range from a low of $6.00 to a high of $6.00, representing a 0% spread in expectations. The median target of $6.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 1 analysts rating the stock as a Buy or Strong Buy,0 rating it Hold, and 1 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.
From a valuation perspective, RR trades at a trailing P/E of -12.7x. Analysts expect EPS to grow -0.8% over the next year.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 BRBSBlue Ridge Bankshares, Inc. | $343M | $3.81 | — | — | — | — | — |
 BBOTBridgeBio Oncology Therapeutics Inc. | $333M | $4.16 | $19.00 | +356.7% | Buy | — | 8 |
 MVSTMicrovast Holdings, Inc. | $232M | $0.70 | $4.80 | +588.7% | Buy | — | 6 |
 NXRTNexPoint Residential Trust, Inc. | $527M | $20.74 | $24.50 | +18.1% | Hold | — | 11 |
 IRBTiRobot Corporation | $2M | $0.05 | — | — | — | — | — |
 BFLYButterfly Network, Inc. | $2.4B | $9.20 | $5.19 | -43.6% | Buy | — | 7 |
 OUSTOuster, Inc. | $2.5B | $39.38 | $61.25 | +55.5% | Buy | — | 10 |
 MBOTMicrobot Medical Inc. | $60M | $1.31 | $5.50 | +319.8% | Buy | — | 3 |
 ISRGIntuitive Surgical, Inc. | $140.7B | $398.30 | $491.15 | +23.3% | Buy | 36.9x | 57 |
 STRCStrategy Inc | $32.7B | $98.91 | $252.00 | +154.8% | Hold | — | 1 |
Quick answers to the most common questions about buying RR stock.
The consensus Wall Street price target for RR is $6, representing 263.6% upside from the current price of $1.65. With 2 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
RR has a consensus rating of "Buy" based on 2 Wall Street analysts. The rating breakdown is mixed, with 0 Hold ratings making up the largest segment. The consensus 12-month price target of $6 implies 263.6% upside from current levels.
RR's current price is $1.65 with a consensus target of $6 (263.6% implied move). Analyst estimates suggest the stock is undervalued at current levels.
The most bullish Wall Street analyst has a price target of $6 for RR, while the most conservative target is $6. The consensus of $6 represents the median expectation. These targets typically reflect 12-month expectations.
RR is lightly followed, with 2 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 1 have Buy ratings, 0 recommend Hold, and 1 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month RR stock forecast based on 2 Wall Street analysts shows a consensus price target of $6, with estimates ranging from $6 (bear case) to $6 (bull case). The median consensus rating is "Buy".
Wall Street analysts are very optimistic on RR, with a "Buy" consensus rating and $6 price target (263.6% upside). 1 of 2 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
RR analyst price targets range from $6 to $6, a 0% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $6 consensus represents the middle ground.
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.